A

Amit M. Oza

Ontario Institute for Cancer Research

ORCID: 0000-0002-9510-8641

1.2k papers and 57.9k citations.

PubIndex Score98Top 2%How it's scored

1.2kPublications

57.9kTotal Citations

First publication: 1990First senior author: 1997

Top publicationsby citations

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

Mansoor R. Mirza, Ursula A. Matulonis, Antonio González-Martı́n et al.|New England Journal of Medicine|2016

Cited by 2.5k

Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial

Camilla Zimmermann, Christopher Lo, Nadia Swami et al.|The Lancet|2014

Cited by 1.8k

Rethinking ovarian cancer: recommendations for improving outcomes

Sebastian Vaughan, Frances R. Balkwill, Jermaine Coward et al.|Nature reviews. Cancer|2011

Cited by 1.5k

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

Kathleen N. Moore, Bradley J. Monk, Angeles Alvarez Secord et al.|The Lancet Oncology|2019

Cited by 533

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

Andrés Poveda, Nicolas Pécuchet, Anne Floquet et al.|The Lancet Oncology|2021

Cited by 412

Indexing the rest of 1,228 publications…